⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LYEL News
Lyell Immunopharma, Inc. Common Stock
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2025
globenewswire.com
LYEL
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
globenewswire.com
LYEL
Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
globenewswire.com
LYEL